Pear Therapeutics, Inc. logo

Pear Therapeutics, Inc. (PEARW)

Market Closed
18 Apr, 20:00
NASDAQ (NMS) NASDAQ (NMS)
$
0. 01
0
0%
$
4.09M Market Cap
- P/E Ratio
- Div Yield
471,836 Volume
- Eps
$ 0.01
Previous Close
Add Transaction
Day Range
0 0.01
Year Range
0 0.01
Want to track PEARW and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

PEARW closed Tuesday higher at $0.01, an increase of 0% from Monday's close, completing a monthly increase of 0% or $0.01. Over the past 12 months, PEARW stock gained 0%.
PEARW is not paying dividends to its shareholders.
The stock of the company had never split.
The company's stock is traded on one exchange.

PEARW Chart

People also search for

Fractyl Health Inc.
$ 0.7
+3.9704%
TScan Therapeutics Inc.
$ 0.78
+1.2777%
GreenLight Biosciences Holdings
$ 0.3
-0.0334%
Bioharvest Sciences Inc.
$ 2.08
-1.1905%
Sify Technologies Limited Rights expiring 6/21/2024
$ 0.18
+2.0571%

Pear Therapeutics, Inc. (PEARW) FAQ

What is the stock price today?

The current price is $0.01.

On which exchange is it traded?

Pear Therapeutics, Inc. is listed on NASDAQ (NMS).

What is its stock symbol?

The ticker symbol is PEARW.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 4.09M.

Has Pear Therapeutics, Inc. ever had a stock split?

No, there has never been a stock split.

Pear Therapeutics, Inc. Profile

Biotechnology Industry
Healthcare Sector
Christopher D. T. Guiffre MBA CEO
NASDAQ (NMS) Exchange
704723113 CUSIP
US Country
200 Employees
- Last Dividend
- Last Split
- IPO Date

Overview

Pear Therapeutics, Inc. is a pioneering company focused on the development and market introduction of innovative software-driven medical therapies. Established in 2013, Pear Therapeutics is headquartered in Boston, Massachusetts, and has carved a niche for itself in the realm of digital health solutions. The company is committed to addressing complex psychiatric and neurological conditions, boasting a diverse and expanding portfolio of digital products and candidates that cater to various severe health conditions. Through its unique approach, Pear Therapeutics aims to enhance patient care by integrating technology with therapeutic interventions, thereby redefining treatment paradigms in the healthcare industry.

Products and Services

  • PearConnect

    PearConnect serves as a comprehensive support hub designed specifically for users of Pear Therapeutics' prescription digital therapeutics. It provides resources, tools, and support to help patients maximize their treatment experience, ensuring they have access to guidance and assistance as they navigate their therapeutic journey.

  • reSET

    reSET is an evidence-based digital therapeutic aimed at aiding individuals in the management of substance use disorder. It incorporates cognitive behavioral therapy principles to help users develop coping skills and strategies, ultimately promoting recovery and reducing the risk of relapse.

  • reSET-O

    Targeting opioid use disorder specifically, reSET-O is a prescription digital therapeutic that assists patients in addressing their addiction to opioids. The platform facilitates a structured and supportive treatment experience, offering tailored interventions to help individuals achieve sustainable recovery.

  • Somryst

    Somryst is a digital intervention that focuses on chronic insomnia, providing users with a behavioral therapy framework aimed at improving sleep patterns and overall sleep quality. By leveraging technology, Somryst empowers patients to take control of their sleep health through engaging and effective treatment protocols.

Contact Information

Address: 200 State Street
Phone: 617 925 7848